What are the key differences between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)?

Key Differences Between DKA and HHS

DKA and HHS differ fundamentally in their biochemical profiles, clinical presentation, and time course: DKA features severe ketoacidosis with glucose typically >250 mg/dL and rapid onset within 24 hours, while HHS presents with extreme hyperglycemia >600 mg/dL, marked hyperosmolality >320 mOsm/kg, minimal ketosis, and insidious development over days to weeks. 1, 2

Biochemical Distinctions

Glucose Levels

• DKA: Plasma glucose typically >250 mg/dL 1, 2
• HHS: Plasma glucose markedly elevated at >600 mg/dL 1, 2

Acid-Base Status

• DKA: Arterial pH ranges from <7.0 to 7.30, with serum bicarbonate ≤18 mEq/L 1, 2
• HHS: Arterial pH >7.30 with serum bicarbonate >15 mEq/L 1, 2
• DKA: Anion gap elevated (>10-12 mEq/L) due to ketoacid accumulation 1, 2
• HHS: Anion gap variable and typically not significantly elevated 1, 2

Ketone Bodies

• DKA: Strongly positive urine and serum ketones due to unregulated lipolysis and ketogenesis from severe insulin deficiency 1, 2
• HHS: Small or negative ketones, as residual insulin is adequate to prevent lipolysis and ketogenesis but insufficient to control hyperglycemia 1, 2

Osmolality

• DKA: Effective serum osmolality is variable 1, 2
• HHS: Markedly elevated effective serum osmolality >320 mOsm/kg, driving the severe hyperosmolar state 1, 2

Pathophysiologic Mechanisms

DKA Pathophysiology

• Triggered by absolute or near-absolute insulin deficiency combined with elevated counterregulatory hormones 1, 2
• Leads to uncontrolled lipolysis with release of free fatty acids from adipose tissue 1
• Drives unrestrained hepatic fatty acid oxidation to ketone bodies (β-hydroxybutyrate and acetoacetate), resulting in ketonemia and metabolic acidosis 1

HHS Pathophysiology

• Characterized by residual β-cell function providing enough insulin to suppress lipolysis and prevent ketogenesis 1, 2
• Insulin remains inadequate to facilitate peripheral glucose utilization, leading to extreme hyperglycemia 1, 2
• The evidence for this mechanism is acknowledged as weak 1

Shared Features

• Both conditions involve glycosuria leading to osmotic diuresis with loss of water, sodium, potassium, and other electrolytes 1
• Typical total body water deficits approximate 6 liters (100 ml/kg) in adults 3
• Significant electrolyte losses include sodium (5-13 mEq/kg) and potassium (5-15 mEq/kg) 3

Clinical Presentation Differences

Time Course

• DKA: Evolves rapidly, typically within 24 hours, allowing for acute presentation with minimal warning 1, 2
• HHS: Develops insidiously over several days to weeks, reflecting the slower progression of severe dehydration 1, 2

Mental Status

• DKA: Patients range from alert to drowsy, with stupor/coma only in severe cases 1, 2
• HHS: Stupor and coma are much more frequent, correlating with the degree of hyperosmolality 1, 2

Respiratory Pattern

• DKA: Kussmaul respirations (deep, rapid breathing) are characteristic, representing respiratory compensation for metabolic acidosis 1, 2
• HHS: Kussmaul respirations are absent due to lack of significant acidosis 2

Gastrointestinal Symptoms

• DKA: Abdominal pain and vomiting occur in up to 25% of patients, sometimes with coffee-ground emesis from hemorrhagic gastritis 1, 2
• HHS: Abdominal pain is not a typical feature 2

Shared Clinical Features

• Both present with polyuria, polydipsia, polyphagia, weight loss, dehydration, and weakness 1
• Poor skin turgor, tachycardia, and hypotension occur in both conditions 1
• Patients can be normothermic or even hypothermic despite infection; hypothermia is a poor prognostic sign 1, 2

Dehydration Severity

• DKA: Moderate dehydration occurs from osmotic diuresis 2
• HHS: Profound dehydration is the hallmark, often more severe than in DKA, contributing to higher mortality 2

Mortality and Prognosis

• DKA: Mortality rate approximately 5% in experienced centers, with lower rates in younger patients 2
• HHS: Mortality rate significantly higher at approximately 15%, reflecting older age of patients, greater comorbidity burden, and severity of hyperosmolality 2
• Both conditions have worse outcomes at extremes of age (>65 years), in the presence of coma, hypotension, and hypothermia 2

Precipitating Factors

Common to Both

• Infection is the single most common precipitating factor for both DKA and HHS, accounting for 30-50% of cases 1, 4
• Other shared precipitants include cerebrovascular accident, myocardial infarction, pancreatitis, trauma, and drugs affecting carbohydrate metabolism (corticosteroids, thiazides, sympathomimetic agents) 1, 4

DKA-Specific

• New-onset type 1 diabetes or discontinuation/inadequate insulin in established type 1 diabetes 1
• SGLT2 inhibitors are now a leading cause of DKA, including euglycemic DKA 4
• Insulin omission, particularly in patients with psychiatric illness, eating disorders, or financial constraints 4

HHS-Specific

• Elderly individuals with new-onset diabetes (particularly residents of chronic care facilities) or those unable to access fluids when hyperglycemic 1

Common Pitfalls

Diagnostic Challenges

• Euglycemic DKA can occur with SGLT2 inhibitors, causing DKA with glucose levels <250 mg/dL, potentially delaying diagnosis if clinicians rely solely on glucose thresholds 2
• Temperature is unreliable for detecting infection; patients may be normothermic or hypothermic despite serious infection 1, 2

Overlapping Features

• Features of both disorders with ketoacidosis and hyperosmolality may coexist, creating a mixed presentation 5, 6
• HHS-DKA patients have significantly higher rates of acute kidney injury (84%) and hyperkalemia (58%) compared to those with DKA or HHS alone 6